lobbying_activities: 3801917
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3801917 | 6a7a350a-ea76-409a-9a95-39b5b2e4b3c7 | Q1 | DS2 GROUP, LLC | 400694066 | ROCHE DIAGNOSTICS | 2026 | first_quarter | HCR | Ensuring Patient Access to Critical Breakthrough Products Act; HR 5269: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act | HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2026-04-02T13:46:54-04:00 |